BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 7706320)

  • 1. Purification and characterization of a naturally occurring vascular endothelial growth factor.placenta growth factor heterodimer.
    DiSalvo J; Bayne ML; Conn G; Kwok PW; Trivedi PG; Soderman DD; Palisi TM; Sullivan KA; Thomas KA
    J Biol Chem; 1995 Mar; 270(13):7717-23. PubMed ID: 7706320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterodimers of placenta growth factor/vascular endothelial growth factor. Endothelial activity, tumor cell expression, and high affinity binding to Flk-1/KDR.
    Cao Y; Chen H; Zhou L; Chiang MK; Anand-Apte B; Weatherbee JA; Wang Y; Fang F; Flanagan JG; Tsang ML
    J Biol Chem; 1996 Feb; 271(6):3154-62. PubMed ID: 8621715
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and physiological activity of heterodimers comprising different splice forms of vascular endothelial growth factor and placenta growth factor.
    Birkenhäger R; Schneppe B; Röckl W; Wilting J; Weich HA; McCarthy JE
    Biochem J; 1996 Jun; 316 ( Pt 3)(Pt 3):703-7. PubMed ID: 8670141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Upregulation of the angiogenic factors PlGF, VEGF and their receptors (Flt-1, Flk-1/KDR) by TSH in cultured thyrocytes and in the thyroid gland of thiouracil-fed rats suggest a TSH-dependent paracrine mechanism for goiter hypervascularization.
    Viglietto G; Romano A; Manzo G; Chiappetta G; Paoletti I; Califano D; Galati MG; Mauriello V; Bruni P; Lago CT; Fusco A; Persico MG
    Oncogene; 1997 Nov; 15(22):2687-98. PubMed ID: 9400995
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel method to purify recombinant vascular endothelial growth factor (VEGF121) expressed in yeast.
    Mohanraj D; Olson T; Ramakrishnan S
    Biochem Biophys Res Commun; 1995 Oct; 215(2):750-6. PubMed ID: 7488018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolation of a human placenta cDNA coding for a protein related to the vascular permeability factor.
    Maglione D; Guerriero V; Viglietto G; Delli-Bovi P; Persico MG
    Proc Natl Acad Sci U S A; 1991 Oct; 88(20):9267-71. PubMed ID: 1924389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo angiogenic activity and hypoxia induction of heterodimers of placenta growth factor/vascular endothelial growth factor.
    Cao Y; Linden P; Shima D; Browne F; Folkman J
    J Clin Invest; 1996 Dec; 98(11):2507-11. PubMed ID: 8958213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A heparin-binding form of placenta growth factor (PlGF-2) is expressed in human umbilical vein endothelial cells and in placenta.
    Hauser S; Weich HA
    Growth Factors; 1993; 9(4):259-68. PubMed ID: 8148155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetics of placenta growth factor/vascular endothelial growth factor synergy in endothelial hydraulic conductivity and proliferation.
    Dull RO; Yuan J; Chang YS; Tarbell J; Jain RK; Munn LL
    Microvasc Res; 2001 Mar; 61(2):203-10. PubMed ID: 11254400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Placenta growth factor stimulates MAP kinase and mitogenicity but not phospholipase C-gamma and migration of endothelial cells expressing Flt 1.
    Landgren E; Schiller P; Cao Y; Claesson-Welsh L
    Oncogene; 1998 Jan; 16(3):359-67. PubMed ID: 9467961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of vascular endothelial growth factor, placental growth factor, and their receptors Flt-1 and KDR in human placenta under pathologic conditions.
    Kumazaki K; Nakayama M; Suehara N; Wada Y
    Hum Pathol; 2002 Nov; 33(11):1069-77. PubMed ID: 12454810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of angiogenic growth factor combinations on retinal endothelial cells.
    Castellon R; Hamdi HK; Sacerio I; Aoki AM; Kenney MC; Ljubimov AV
    Exp Eye Res; 2002 Apr; 74(4):523-35. PubMed ID: 12076096
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular endothelial growth factor is induced in response to transforming growth factor-beta in fibroblastic and epithelial cells.
    Pertovaara L; Kaipainen A; Mustonen T; Orpana A; Ferrara N; Saksela O; Alitalo K
    J Biol Chem; 1994 Mar; 269(9):6271-4. PubMed ID: 8119973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of vascular endothelial growth factor (VEGF) and placental growth factor (PlGF) in conceptus and endometrium during implantation in the rhesus monkey.
    Ghosh D; Sharkey AM; Charnock-Jones DS; Dhawan L; Dhara S; Smith SK; Sengupta J
    Mol Hum Reprod; 2000 Oct; 6(10):935-41. PubMed ID: 11006323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of biologically active human vascular endothelial growth factor in yeast.
    Mohanraj D; Olson T; Ramakrishnan S
    Growth Factors; 1995; 12(1):17-27. PubMed ID: 8527160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Purification of a glycoprotein vascular endothelial cell mitogen from a rat glioma-derived cell line.
    Conn G; Soderman DD; Schaeffer MT; Wile M; Hatcher VB; Thomas KA
    Proc Natl Acad Sci U S A; 1990 Feb; 87(4):1323-7. PubMed ID: 2406719
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Placenta growth factor-1 antagonizes VEGF-induced angiogenesis and tumor growth by the formation of functionally inactive PlGF-1/VEGF heterodimers.
    Eriksson A; Cao R; Pawliuk R; Berg SM; Tsang M; Zhou D; Fleet C; Tritsaris K; Dissing S; Leboulch P; Cao Y
    Cancer Cell; 2002 Feb; 1(1):99-108. PubMed ID: 12086892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Placental growth factor neutralising antibodies give limited anti-angiogenic effects in an in vitro organotypic angiogenesis model.
    Brave SR; Eberlein C; Shibuya M; Wedge SR; Barry ST
    Angiogenesis; 2010 Dec; 13(4):337-47. PubMed ID: 20953695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular endothelial cell growth factor (VEGF) produced by A-431 human epidermoid carcinoma cells and identification of VEGF membrane binding sites.
    Myoken Y; Kayada Y; Okamoto T; Kan M; Sato GH; Sato JD
    Proc Natl Acad Sci U S A; 1991 Jul; 88(13):5819-23. PubMed ID: 1712106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The carboxyl-terminal domain (111-165) of vascular endothelial growth factor is critical for its mitogenic potency.
    Keyt BA; Berleau LT; Nguyen HV; Chen H; Heinsohn H; Vandlen R; Ferrara N
    J Biol Chem; 1996 Mar; 271(13):7788-95. PubMed ID: 8631822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.